Botanical species · safety record

Erythroxylum novogranatense

The EFSA Compendium of Botanicals holds 19 constituent measurements for Erythroxylum novogranatense. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Erythroxylum novogranatense (D.Morris) Hieron.

19Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Calystegines	Leaves	Solvent extraction	≤ 0.32 Percent	GC-FID	Resolve DOI
Cocain	Leaves	Solvent extraction	≥ 0.37 Percent	GC-FID	Resolve DOI
Cocain	Leaves	Solvent extraction	≤ 0.6 Percent	GC-FID	Resolve DOI
Cuscohygrine	Leaves	Solvent extraction	≥ 3.8 Percent	GC-FID	Resolve DOI
Cuscohygrine	Leaves	Solvent extraction	≤ 11 Percent	GC-FID	Resolve DOI
Hydroxytropacocaine	Leaves	Solvent extraction	2.58 Percent	GC-FID	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≤ 0.5 Percent	GC-MS	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≥ 0.3 Percent	GC-MS	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≥ 29 Percent	GC-FID	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≤ 53 Percent	GC-FID	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≤ 63 Percent	GC-FID	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≥ 46 Percent	GC-FID	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≤ 170 Percent	GC-FID	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≥ 1.4 Percent	GC-FID	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≤ 4.6 Percent	GC-FID	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	22.14 Percent	GC-ECD	Resolve DOI
Tropane alkaloids	Leaves	Solvent extraction	≥ 25 Percent	GC-FID	Resolve DOI
Alkaloids	Leaves	—	≤ 2.43 Percent	Unspecified	No resolvable identifier
Alkaloids	Leaves	—	≥ 1.26 Percent	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Johnson, EL., Foy, CD. Biomass accumulation and alkaloid content in leaves of Erythroxylum coca and Erythroxylum novogranatense var novogranatense grown in soil with varying pH . Journal of plant physiology, 1996, vol. 149, no. 3-4, p. 444-450.
MOORE, JM., HAYS, PA., COOPER, DA., CASALE, JF., LYDON, J. 1-HYDROXYTROPACOCAINE - AN ABUNDANT ALKALOID OF ERYTHROXYLUM NOVOGRANATENSE VAR NOVOGRANATENSE AND VAR TRUXILLENSE . Phytochemistry, 1994, vol. 36, no. 2, p. 357-360. DOI
Brock, A., Bieri, S., Christen, P., Drager, B. Calystegines in wild and cultivated Erythroxylum species. PHYTOCHEMISTRY, 2005, vol. 66, no. 11, p. 1231-1240. DOI
MOORE, JM., CASALE, JF., KLEIN, RFX., COOPER, DA., LYDON, J. DETERMINATION AND IN-DEPTH CHROMATOGRAPHIC ANALYSES OF ALKALOIDS IN SOUTH-AMERICAN AND GREENHOUSE-CULTIVATED COCA LEAVES. JOURNAL OF CHROMATOGRAPHY A, 1994, vol. 659, no. 1, p. 163-175. DOI
Casale, John F., Mallette, Jennifer R., Jones, Laura M. Chemosystematic identification of fifteen new cocaine-bearing Erythroxylum cultigens grown in Colombia for illicit cocaine production. FORENSIC SCIENCE INTERNATIONAL, 2014, vol. 237, p. 30-39. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature